We unleash your business potential by maximize the business innovation.
Send EmailDisodium Salt, Pyrroloquinoline Quinone, PQQ Disodium Salt, PQQ, 122628-50-6
| Parameter | Information |
|---|---|
| Product Name | Disodium Salt (Pyrroloquinoline Quinone, PQQ) |
| Chemical Name | PQQ Disodium Salt, Pyrroloquinoline Quinone Disodium Salt |
| CAS Number | 122628-50-6 |
| Molecular Formula | C₁₄H₄N₂O₈Na₂ |
| Molecular Weight | ~374 g/mol |
| Chemical Class | Quinone / Organic acid salt |
| Appearance | Reddish-brown powder |
| Odor | Slight characteristic odor |
| Physical State (20°C) | Solid (powder) |
Pyrroloquinoline quinone (PQQ) is a quinone-class compound discovered in 1979, structurally similar to vitamin B3 (niacin). PQQ disodium salt is the sodium-stabilized form of PQQ. The molecule contains a three-ringed quinone structure and functions as a powerful antioxidant cofactor.
Structural Formula:
O
||
HOOC-C
|
HOOC-C - N - C
| | |
C - C - C
/ \ / \
N C N
| | |
C - C - C - C
| | |
O HOOC O
||
O
Molecular Structure Properties:
| Property | Description |
|---|---|
| Functional Groups | 2 carboxylate groups (-COONa), 2 quinone groups (C=O), 2 nitrogen atoms |
| Ring Structure | Tricyclic (ortho-quinone structure) |
| Cofactor Activity | Cofactor for oxidoreductase enzymes |
| Redox Properties | 2-electron redox cycling |
| Chelating Properties | Can bind metal ions |
| Property | Description |
|---|---|
| Cofactor Function | Electron carrier in oxidoreductase enzymes |
| Antioxidant Activity | Up to 20,000 redox cycles capacity |
| Mitochondrial Biogenesis | Promotes formation of new mitochondria |
| Neuroprotective Effect | Protects neurons against oxidative damage |
| Sirtuin Activation | Increases SIRT1 and SIRT3 activity |
| Property | Value / Description |
|---|---|
| Appearance | Reddish-brown powder |
| Odor | Slight characteristic odor |
| Molecular Formula | C₁₄H₄N₂O₈Na₂ |
| Molecular Weight | ~374 g/mol |
| Purity | ≥ 98.0% (typical) |
| Melting Point | No distinct melting point; tendency to decompose |
| Solubility (Water, 25°C) | Soluble (>10 mg/mL) |
| Solubility (DMSO) | Soluble |
| Solubility (Ethanol) | Slightly soluble |
| pH (1% aqueous solution) | 6.0 – 7.0 |
| Hygroscopicity | Hygroscopic (moisture-absorbing) |
| Light Sensitivity | Sensitive to light |
| Oxygen Sensitivity | Sensitive to oxygen (slow oxidation) |
| Heavy Metals | ≤ 10 ppm |
| Loss on Drying | ≤ 5.0% |
| Ash Content | ≤ 1.0% |
| Parameter | Information |
|---|---|
| Chemical Stability | Stable under normal conditions; sensitive to light, oxygen, and moisture |
| Conditions to Avoid | Light, high temperature, moisture, strong oxidizers, strong reducing agents |
| Incompatible Materials | Strong oxidizing agents, strong reducing agents |
| Hazardous Decomposition Products | Carbon monoxide, carbon dioxide, nitrogen oxides |
| Hazardous Polymerization | Will not occur |
| Light Sensitivity | High; UV and daylight cause color change and degradation |
| Oxygen Sensitivity | Moderate; prolonged air contact causes oxidation |
PQQ can perform up to 20,000 redox cycles due to its unique redox properties. This makes it significantly more effective than other known antioxidants (Vitamin C, Vitamin E).
Redox Cycling:
PQQ (oxidized) + 2e⁻ + 2H⁺ → PQQH₂ (reduced)
PQQH₂ (reduced) → PQQ (oxidized) + 2e⁻ + 2H⁺
| Antioxidant | Redox Cycle Capacity |
|---|---|
| PQQ | Up to 20,000 cycles |
| Vitamin C | ~1-2 cycles |
| Vitamin E | ~1-2 cycles |
| Coenzyme Q10 | ~10-20 cycles |
| Activity | Description |
|---|---|
| Mitochondrial Biogenesis | Promotes new mitochondria formation via PGC-1α activation |
| Neuroprotection | Protects neurons against oxidative stress, neurotoxicity, and ischemia |
| Cardioprotection | Reduces myocardial ischemia-reperfusion injury |
| Neuroinflammation | Reduces neuroinflammation and supports cognitive function |
| Sirtuin Activation | Activates SIRT1 and SIRT3, slowing cellular aging |
| Anti-inflammatory | Reduces inflammatory markers (TNF-α, IL-6) |
| Neurogenesis | Supports neural stem cell proliferation and differentiation |
| Cellular Energy Metabolism | Increases cellular energy production |
| Application | Function | Details |
|---|---|---|
| Antioxidant Supplement | Free radical scavenger | Powerful antioxidant effect |
| Mitochondrial Health | Increased energy production | Promotes new mitochondria formation |
| Neurological Health | Cognitive function support | Supports memory, focus, and cognitive performance |
| Cardiovascular Health | Heart health | Protects heart muscle cells |
| Cellular Aging | Anti-aging | Slows cellular aging via sirtuin activation |
| Sleep Quality | Sleep regulation | Positive effects on circadian rhythm |
| Energy Level | Metabolic support | Improves cellular energy metabolism |
| Application | Function | Details |
|---|---|---|
| Cognitive Support | Neuroprotection | Protects neurons against oxidative damage |
| Neurodegenerative Diseases | Supportive therapy | Potential benefits in Alzheimer's, Parkinson's |
| Stress Resilience | Neuroinflammation reduction | Reduces neurological effects of chronic stress |
| Nerve Regeneration | Neurogenesis | Supports neural stem cell proliferation |
| Application | Function | Details |
|---|---|---|
| Energy Metabolism | Mitochondrial support | Improves exercise performance and recovery |
| Muscle Health | Oxidative stress reduction | Reduces exercise-induced oxidative damage |
| Endurance | Cellular energy | Increases aerobic capacity |
| Application | Function | Details |
|---|---|---|
| Cellular Biology | Cofactor studies | Enzyme catalysis mechanisms |
| Neuroscience | Neuroprotection research | Neurodegenerative disease models |
| Mitochondrial Research | Biogenesis studies | Mitochondrial formation and function mechanisms |
| Aging Research | Anti-aging studies | Investigation of cellular aging processes |
| Clinical Studies | Pharmacological applications | Discovery of new therapeutic areas |
| Application | Recommended Daily Dosage | Note |
|---|---|---|
| General Antioxidant Supplement | 10 – 20 mg | Typical adult dose |
| Mitochondrial Support | 20 – 40 mg | High dosage |
| Neurological Health | 10 – 30 mg | Range used in clinical studies |
| Sports Performance | 10 – 20 mg | Pre- or post-exercise |
Note: Medical conditions require physician consultation. In the US and Europe, up to 20 mg/day is common for supplementation.
| Parameter | Information |
|---|---|
| Oral Bioavailability | Low (~5-10%) |
| Plasma Peak Time (Tmax) | ~1-3 hours |
| Half-Life (t½) | ~0.5-2 hours |
| Elimination Route | Renal excretion (urine) |
| Protein Binding | High (~90%) |
| Metabolism | Hepatic sulfation and glucuronidation |
| Parameter | Value |
|---|---|
| Acute Oral Toxicity (LD50, Rat) | > 5,000 mg/kg (very low toxicity) |
| NOAEL (Repeated Dose) | 100 mg/kg/day (rat, 90 days) |
| Skin Irritation | Mild irritant |
| Eye Irritation | Mild irritant |
| Inhalation | Dust may cause respiratory tract irritation |
| Carcinogenicity | Not classified as a carcinogen |
| Mutagenicity | Not mutagenic |
| Reproductive Toxicity | No significant toxicity observed |
| Genotoxicity | Negative |
| ADI (Acceptable Daily Intake) | Safe up to 20 mg/day (GRAS status) |
| Hazard Class | Category | H-Statement |
|---|---|---|
| No significant hazard classification | – | – |
Signal Word: None
Hazard Pictograms: None
Hazard Statements: No H-codes
Environmental Information: No data indicating environmental hazards.
| Code | Statement |
|---|---|
| P261 | Avoid breathing dust |
| P264 | Wash hands thoroughly after handling |
| P271 | Use only in well-ventilated areas |
| P280 | Wear protective gloves/eye protection/face protection |
| P304+P340 | IF INHALED: Remove person to fresh air and keep comfortable for breathing |
| P305+P351+P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present |
| P337+P313 | If eye irritation persists: Get medical advice/attention |
| P501 | Dispose of contents/container in accordance with local regulations |
| Route of Exposure | Action to Be Taken |
|---|---|
| Inhalation | Move to fresh air. If symptoms persist, seek medical attention |
| Skin Contact | Wash with plenty of soap and water. Remove contaminated clothing |
| Eye Contact | Rinse thoroughly with plenty of water for at least 15 minutes. Remove contact lenses. If irritation persists, seek medical attention |
| Ingestion | Rinse mouth. If conscious, drink water. Do not induce vomiting. Seek medical attention |
| Parameter | Condition |
|---|---|
| Storage Conditions | Store in a cool, dry, light-protected environment |
| Container Requirements | Keep in original packaging, protected from moisture |
| Light Protection | Light-proof packaging (aluminum foil) |
| Moisture Protection | Silica gel recommended |
| Temperature | Room temperature (15-25°C) |
| Shelf Life | 24 months in unopened original packaging under proper storage conditions |
| After Opening | Use promptly; store under inert gas (nitrogen) |
| Packaging Type | Quantity | Material |
|---|---|---|
| Aluminum Foil Bag | 1 kg, 5 kg, 10 kg | Light-proof, moisture-proof, inert gas flushed |
| Fiber Drum | 25 kg | PE-lined, light-proof |
| Small HDPE Containers | 10 g, 50 g, 100 g, 500 g | Light-proof, moisture-proof |
| Parameter | Information |
|---|---|
| UN Number | Not applicable (not dangerous goods) |
| Hazard Class | Not applicable |
| Packing Group | Not applicable |
| ADR/RID | Not regulated |
| IMDG | Not regulated |
| IATA | Not regulated |
| Transport Temperature | Ambient; protect from light, moisture, and heat |
| Region / Authority | Status |
|---|---|
| USA (FDA) | GRAS; GRN No. 917, GRN No. 1118 |
| European Union (EFSA) | Not approved as novel food; can be marketed as supplement in EU member states |
| Turkey | Can be used as dietary supplement raw material |
| Japan | Approved as food and supplement ingredient |
| China | Limited use as medicinal ingredient |
| Israel | Approved food ingredient |
| Parameter | Information |
|---|---|
| Biodegradability | Readily biodegradable |
| Aquatic Toxicity | Low toxicity |
| Bioaccumulation | Not expected |
| Environmental Precautions | Avoid large releases into water bodies |
Pyrroloquinoline Quinone Disodium Salt
PQQ Disodium Salt
PQQ-Na₂
Disodium Pyrroloquinoline Quinone
Methoxatin Disodium Salt
4,5-Dihydro-4,5-dioxo-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid disodium salt
| Property | Value |
|---|---|
| CAS Number | 122628-50-6 |
| Molecular Formula | C₁₄H₄N₂O₈Na₂ |
| Molecular Weight | ~374 g/mol |
| Appearance | Reddish-brown powder |
| Purity | ≥ 98.0% |
| Solubility (Water) | >10 mg/mL |
| pH (1% solution) | 6.0 – 7.0 |
| Antioxidant Capacity | Up to 20,000 redox cycles |
| Oral Bioavailability | ~5-10% |
| Plasma Half-Life | ~0.5-2 hours |
| Shelf Life | 24 months |
| FDA Status | GRAS |
| GHS Signal Word | None |
| UN Number | Not applicable |
Light Sensitivity: PQQ disodium salt is highly sensitive to light. Rapid degradation occurs when exposed to UV and daylight. Must be stored in light-proof packaging.
Moisture Sensitivity: Hygroscopic; caking and degradation may occur in humid environments. Silica gel is recommended.
Oxygen Sensitivity: Oxidation may occur with prolonged air contact. Inert gas (nitrogen) storage is recommended.
Dosage Caution: High doses may cause gastrointestinal discomfort (nausea, diarrhea). Use within recommended dosage range.
Bioavailability: Oral bioavailability is low (~5-10%). Consider bioavailability-enhancing strategies (liposomes, cyclodextrins, etc.) in formulation studies.
Drug Interactions: Theoretically may affect the efficacy of some drugs due to antioxidant properties. Clinical studies are limited.
Food Applications: Pure PQQ may cause color changes in food products. This should be considered in formulation studies.
Storage:
Store in a cool, dry, light-protected environment
Use light-proof (aluminum foil) packaging
Use silica gel for moisture protection
Store under inert gas (nitrogen)
Store at room temperature (15-25°C)
Formulation:
Can be used in capsules, tablets, powders, or liquid formulations
Maintains stability in acidic environments
Soluble in water, but should not be stored in solution
Can be combined with other antioxidants (Vitamin C, Vitamin E) for synergistic effects
Handling:
Use dust mask, protective goggles, and gloves
Avoid dust formation
Use in well-ventilated areas
Wash hands after handling
Avoid inhalation of powder
Waste Management:
Dispose in accordance with local regulations
Avoid release into the environment
Dosage:
Daily dose: 10-20 mg (general antioxidant supplement)
High dose: 20-40 mg (mitochondrial support)
Medical conditions require physician consultation
This Technical Data Sheet (TDS) is for informational purposes only and is prepared based on available technical data. The user is solely responsible for determining the suitability of the product for their specific application and for complying with all local, national, and international regulations. For complete safety, storage, handling, transport, waste, and regulatory compliance information, the official Safety Data Sheet (SDS/MSDS) provided by the manufacturer/supplier must be consulted. This document does not substitute professional advice. Dosage and application conditions should be optimized through product-specific trials. Regulatory status of PQQ disodium salt may vary by country; verify compliance before use. For medical use, consultation with a healthcare professional is mandatory.